Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New SwallowFit exercise aims to ease Parkinson's swallowing problems

NCT ID NCT07356414

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study tests a 6-week exercise program called SwallowFit designed to improve swallowing fitness in people with Parkinson's disease. Researchers will compare the exercise group to those receiving standard care. The goal is to see if the exercises lead to safer swallowing and better quality of life for 80 U.S. service members, veterans, and their families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SwallowFit exercise program (swallowing exercises)
What this could lead to
If it works, this could provide a simple exercise program to help people with Parkinson's swallow more safely and improve their quality of life.
What could go wrong
This is a small, early-stage trial with only 80 participants. The exercises may not work for everyone, and results may not apply to all Parkinson's patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult S-VWP between \>35-90 years of age 2. Diagnosis of Idiopathic Parkinson's Disease \[IDP\] (either or suspected, tremor-predominant or rigid predominant) 3. Disability level of Hoehn \& Yahr stages II-III as indicated in their most recent neurological evaluation 4. Swallowing concern, confirmed by Modified Unified Parkinson Disease Rating Scale \[MDS-UPDRS\]- 5. ADL swallowing item \>0, or Mann Assessment of Swallowing scale \[MASA\] score ≤185. 6. Able to consume oral nutrition \[Functional Oral Intake Score ≤ 6\] 7. Ambulatory 8. No change of medication for at least 4 weeks before study inclusion Exclusion Criteria: 1. Classified as Hoehn and Yahr stages IV 2. Unable to follow 2 step commands 3. History of other neurological disease potentially causing dysphagia 4. Dementia (MMSE\<20; Montreal cognitive assessment (MoCA) ≤ 20) 5. Severe depression (BDI\>19) 6. Severe dyskinesia of head and neck (resulting in problems with MBSS recording) 7. Severe documented Gastrointestinal disease 8. History of Gastro-esophageal surgery 9. History of Head or neck cancer with swallowing impairment or surgical intervention 10. History of breathing disorders or diseases (e.g., Asthma, chronic obstructive pulmonary disease (COPD) requiring assistive breathing support. 11. Untreated hypertension 12. Heart disease requiring restricted activity and medical intervention 13. Speech therapy intervention for swallowing within the past three months 14. Women who are pregnant, nursing, or who plan to become pregnant during the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease (disorder) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Brooke Army Medical Center (BAMC)

    San Antonio, Texas, 78234-6200, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.